Observational studyRheumatology international2021

Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience.

Michalis P Migkos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.